Collectively, the rapid decrease in sgRNA levels, the low level of viral mutations in the S protein, and the absence of an anamnestic response after challenge emphasize SARS-CoV-2 S-I53-50NP vaccination’s profound ability to control infection and replication. This evidence concerns the gene PROS1 and infection.